BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9950238)

  • 21. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study.
    Ishibe N; Hankinson SE; Colditz GA; Spiegelman D; Willett WC; Speizer FE; Kelsey KT; Hunter DJ
    Cancer Res; 1998 Feb; 58(4):667-71. PubMed ID: 9485019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2'-bis(p-chlorophenyl)ethylene.
    Zheng T; Holford TR; Mayne ST; Tessari J; Ward B; Carter D; Owens PH; Boyle P; Dubrow R; Archibeque-Engle S; Dawood O; Zahm SH
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):167-74. PubMed ID: 10698477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms in CYP1A1 and breast carcinoma risk in a population-based case-control study of Chinese women.
    Boyapati SM; Shu XO; Gao YT; Cai Q; Jin F; Zheng W
    Cancer; 2005 Jun; 103(11):2228-35. PubMed ID: 15856430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer.
    Helzlsouer KJ; Alberg AJ; Huang HY; Hoffman SC; Strickland PT; Brock JW; Burse VW; Needham LL; Bell DA; Lavigne JA; Yager JD; Comstock GW
    Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):525-32. PubMed ID: 10385143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutathione transferase polymorphisms and risk of endometriosis associated with polychlorinated biphenyls exposure in Italian women: a gene-environment interaction.
    Vichi S; Medda E; Ingelido AM; Ferro A; Resta S; Porpora MG; Abballe A; Nisticò L; De Felip E; Gemma S; Testai E
    Fertil Steril; 2012 May; 97(5):1143-51.e1-3. PubMed ID: 22424617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer.
    Shields PG; Ambrosone CB; Graham S; Bowman ED; Harrington AM; Gillenwater KA; Marshall JR; Vena JE; Laughlin R; Nemoto T; Freudenheim JL
    Mol Carcinog; 1996 Nov; 17(3):144-50. PubMed ID: 8944074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility.
    Xu X; Kelsey KT; Wiencke JK; Wain JC; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):687-92. PubMed ID: 8877059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism.
    Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
    Cancer Causes Control; 2005 Jun; 16(5):579-85. PubMed ID: 15986113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms of phase I metabolizing enzyme genes, their interaction with lifetime grilled and smoked meat intake, and breast cancer incidence.
    Parada H; Steck SE; Cleveland RJ; Teitelbaum SL; Neugut AI; Santella RM; Gammon MD
    Ann Epidemiol; 2017 Mar; 27(3):208-214.e1. PubMed ID: 27956118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYP1A1 I462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai, China.
    London SJ; Yuan JM; Coetzee GA; Gao YT; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):987-91. PubMed ID: 11008920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of proposed frameworks for grouping polychlorinated biphenyl (PCB) congener data into meaningful analytic units.
    Moysich KB; Mendola P; Schisterman EF; Freudenheim JL; Ambrosone CB; Vena JE; Shields PG; Kostyniak P; Greizerstein H; Graham S; Marshall JR
    Am J Ind Med; 1999 Mar; 35(3):223-31. PubMed ID: 9987555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cytochrome P450 1A1 and uridine-diphosphate-glucuronosyltransferase 1A1 allelic polymorphisms on the risk of development and the prognosis of head and neck cancers.
    Szanyi I; Ráth G; Móricz P; Somogyvári K; Révész P; Gerlinger I; Orsós Z; Ember I; Kiss I
    Eur J Cancer Prev; 2012 Nov; 21(6):560-8. PubMed ID: 22273851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer.
    Ambrosone CB; Freudenheim JL; Thompson PA; Bowman E; Vena JE; Marshall JR; Graham S; Laughlin R; Nemoto T; Shields PG
    Cancer Res; 1999 Feb; 59(3):602-6. PubMed ID: 9973207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of CYP1A1, GSTT1 and GSTM1 polymorphisms on the risk of lung cancer: a case-control study.
    Atinkaya C; Taspinar M; Sakiragaoglu O; Oz G; Yazici U; Oztuna D; Tastepe I; Sunguroglu A
    Hum Exp Toxicol; 2012 Oct; 31(10):1074-80. PubMed ID: 22893352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CYP1A1 gene polymorphisms: lack of association with breast cancer susceptibility in the southern region (Madurai) of India.
    Kiruthiga PV; Kannan MR; Saraswathi C; Pandian SK; Devi KP
    Asian Pac J Cancer Prev; 2011; 12(8):2133-8. PubMed ID: 22292665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the aromatic hydrocarbon receptor gene and its expression in Atlantic tomcod.
    Roy NK; Wirgin I
    Arch Biochem Biophys; 1997 Aug; 344(2):373-86. PubMed ID: 9264552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population.
    Hirvonen A; Husgafvel-Pursiainen K; Karjalainen A; Anttila S; Vainio H
    Cancer Epidemiol Biomarkers Prev; 1992; 1(6):485-9. PubMed ID: 1284589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
    Srivastava DS; Mandhani A; Mittal RD
    Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer.
    Wright CM; Larsen JE; Colosimo ML; Barr JJ; Chen L; McLachlan RE; Yang IA; Bowman RV; Fong KM
    Eur Respir J; 2010 Jan; 35(1):152-9. PubMed ID: 19608585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
    Xie D; Shu XO; Deng Z; Wen WQ; Creek KE; Dai Q; Gao YT; Jin F; Zheng W
    J Natl Cancer Inst; 2000 Mar; 92(5):412-7. PubMed ID: 10699071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.